[1] LIU Xing SHEN Lu MA Fang CHEN Chu,.Discussion on Diabetes Retinopathy Based on “Xuanfu Collateral” Theory [J]. Modern Traditional Chinese Medicine, 2023, (06): 31-35. [doi: 10.13424/j.cnki.mtcm.2023.06.007]
Discussion on Diabetes Retinopathy Based on “Xuanfu Collateral” Theory
- Article number:
- 1672-0571(2023)06-0031-05
- Keywords:
- Key words:Diabetes retinopathy; Collateral vessels; Xuanfu; Supplementing deficiency and unblocking collaterals; opening and nourishing Xuanfu; Spicy wind drugs
- ZTFLH:
- R224；R255.4
- Code:
- A
- Abstract:
- Abstract：The Xuanfu and collateral channels cover the entire body, and maintain the circulation of Qi, blood, and body fluids throughout the body. Diabetes retinopathy in Chinese medicine belongs to the internal barrier of Xiaoke, which is developed from diabetes. After a long period of time, the veins are blocked, the Xuanfu is blocked, and the Shen activity is lost. Based on the theory of “Xuanfu Collateral”, this paper expounds the structure and function of the eye collateral and the eye Xuanfu, analyzes that the pathogenesis of diabetes retinopathy under the “Xuanfu Collateral” is Xuanfu stasis and collateral stasis, and believes that the main pathogenesis of collateral diseases is deficiency, and the main pathogenesis of Xuanfu is occlusion. On this basis, the treatment principle should be based on unblocking collateral and opening Xuanfu. In clinical treatment, we advocate tonifying deficiency to dredge collaterals, and pungent medicine to open Xuanfu, providing ideas for clinical treatment of diabetes retinopathy.
References:
［1］张银银,郑应红,韩文哲,等.李新华从肝论治糖尿病视网膜病变经验［J］.实用中医药杂志,2022,38(5):843-844.
［2］李秀,刘畅.炎症在糖尿病视网膜病变中的作用［J］.国际眼科杂志,2021,21(8):1368-1372.
［3］Song SJ,Wong TY.Current concepts in diabetic retinopathy［J］.Diabetes & Metabolism Journal,2014,38(6):416-425.
［4］Kuo JZ,Wong TY,Rotter JI.Challenges in elucidating the genetics of diabetic retinopathy［J］.JAMA Ophthalmology,2014,132(1):96.
［5］冉德聪,张忠勇,王晓蕴,等.中医防治糖尿病视网膜病变的研究进展［J］.河北中医药学报，2022,37(1):57-60,64.
［6］李雪萍,高永翔,龚圆渊,等.青藤碱“开玄府-通经络-息内风”防治动脉粥样硬化［J］.中国中医基础医学杂志,2018,24(5):675-676,709.
［7］范洪桥,刘丽芳,周亮,等.基于玄府气液理论探讨溻渍法的作用机制［J］.湖南中医药大学学报,2019,39(3):345-347.
［8］张海波.《秘传眼科龙木论》运用通法治疗眼科疾病学术思想探析［J］.现代中医药,2020,40(3):41-42,49.
［9］方芳,王杰鹏,王浩,等.刘完素“玄府气液学说”研究与述评［J］.河北中医药学报,2022,37(2):10-15.
［10］黄高孝,张宝成,黎氏宝玲,等.基于“开玄府,通络脉”理论探讨风药泄浊化瘀在痛风性关节炎治疗中的应用［J］.中国中医急症,2019,28(10):1806-1809.
［11］冯释纬.络脉-玄府理论与慢性复杂性疾病的关系研究［J］.中华中医药杂志,2020,35(3):1544-1547.
［12］郭丹萍,李敏,寇久社,等.益气明目汤配合激光光凝治疗糖尿病视网膜病变57例［J］.现代中医药,2017,37(6):81-83.
［13］Wei X,Balne PK,Meissner KE,et al.Assessment of flow dynamics in retinal and choroidal microcirculation［J］.Survey of Ophthalmology,2018,63(5):646-664.
［14］杨辰华,朱翠翠,张社峰.论糖尿病肾病“络脉-玄府”病机及辛味药的应用［J］.广州中医药大学学报,2021,38(4):838-841.
［15］张艺馨,张效科.从“玄府-络脉”论治糖尿病周围神经病变［J］.北京中医药大学学报,2021,44(11):1034-1038.
［16］向圣锦,路雪婧,张富文,等.中医眼科玄府理论源流探析［J］.中国中医基础医学杂志,2021,27(1):24-27.
［17］高辉,刘怀栋.糖尿病视网膜病变的玄府病机及治疗思路［J］.河北中医,2010,32(4):574-575.
［18］卜祥辉,安海燕,郭晓媛,等.糖尿病肾病与糖尿病视网膜病变中医相关性探讨［J］.湖南中医药大学学报,2022,42(3):486-491.
［19］谈钰濛,胡骏,倪青.从玄府论糖尿病视网膜病变［J］.天津中医药大学学报,2019,38(6):551-553.
［20］秦魏,郭蒙,李欣雨,等.中药单体治疗糖尿病视网膜病变的研究进展［J］.国际眼科杂志,2021,21(8):1373-1377.
［21］刘珣,公婷,钟文,等.白藜芦醇对糖尿病视网膜病变大鼠的作用［J］.潍坊医学院学报,2021,43(5):346-348.
［22］王锦慧,朱钧晶,马蕾,等.《黄帝内经》“辛味”探析［J］.浙江中医药大学学报,2018,42(5):408-410.
［23］李英,高娜,黄群,等.补阳还五汤加减辅助治疗气阴两虚兼血瘀型非增殖期糖尿病视网膜病变［J］.国际眼科杂志,2022,22(1):99-103.
［24］刘嘉宇,孔启航,苏国辉,等.枸杞多糖改善视网膜血管病变机制研究进展［J］.中药材,2021,44(11):2736-2741.
［25］罗再琼,黄淑芬,王明杰.论风药的活血作用及其特点［J］.中医杂志,2000,41(8):453-454.
Memo
基金项目：国家中医药管理局中医学术流派传承工作室第二轮建设项目（国中医人教函（2019）62号）